ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,832.87
0.16%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zymeworks Inc (ZYME)

  7. Zymeworks Inc (ZYME) News

ZYME

Zymeworks (ZYME)

Zymeworks Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZYME
DateTimeSourceHeadlineSymbolCompany
05/28/20245:30AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
05/02/20243:05PMGlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
04/30/20245:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
04/11/20245:00AMGlobeNewswire Inc.Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:ZYMEZymeworks Inc
04/08/20245:00AMGlobeNewswire Inc.Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
03/28/20245:00AMGlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
03/27/20245:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
03/07/20243:46PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZYMEZymeworks Inc
03/07/20243:36PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZYMEZymeworks Inc
03/06/20244:25PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ZYMEZymeworks Inc
03/06/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
03/06/20243:09PMGlobeNewswire Inc.Zymeworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
03/05/20243:30PMGlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
02/27/20245:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
02/22/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
02/14/20245:00AMGlobeNewswire Inc.Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
02/08/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
02/08/20245:00AMGlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
01/31/20245:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
01/08/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20248:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20248:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
01/04/20245:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
01/04/20245:15AMGlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025NASDAQ:ZYMEZymeworks Inc
01/04/20245:00AMGlobeNewswire Inc.Zymeworks Announces Additional Leadership AppointmentsNASDAQ:ZYMEZymeworks Inc
01/03/20243:32PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZYMEZymeworks Inc
12/26/20237:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
12/26/20237:00AMGlobeNewswire Inc.Zymeworks Announces $50 Million Private Placement to EcoR1 CapitalNASDAQ:ZYMEZymeworks Inc
12/15/20237:30AMGlobeNewswire Inc.Zymeworks Added to Nasdaq Biotechnology IndexNASDAQ:ZYMEZymeworks Inc
 Showing the most relevant articles for your search:NASDAQ:ZYME

Your Recent History

NASDAQ
OXACW
Oxbridge Acquisition
LSE
72NI
Sigma Fin.2.63%
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved